Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002

Clinical trial NCT06832982 · RECRUITING

Trial details

NCT number: NCT06832982
Sponsor: Shanghai Pushi Medical Science Co. Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-02-24
Primary completion: 2028-02-19
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.